Desq Long
Sign in
SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 1,333,975 shares; price not stated (see filing).

Reporting Persons ORBIMED ADVISORS LLC · OrbiMed Capital GP VII LLC · OrbiMed Israel GP II, L.P. · OrbiMed Advisors Israel II Ltd · OrbiMed Genesis GP LLC · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "ADARx Pharmaceuticals, Inc. (ADRX)." Disclosed 2026-09-30. https://desqlong.com/cards/0000947871-26-000910-7 (retrieved 2026-10-01).